{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:45:13Z","timestamp":1791747913752,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T00:00:00Z","timestamp":1489104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T00:00:00Z","timestamp":1489104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-017-0069-5","type":"journal-article","created":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T16:21:12Z","timestamp":1489162872000},"page":"875-881","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Evaluation of the Potency, Neutralizing Antibody Response, and Stability of a Recombinant Fusion Protein Vaccine for Streptococcus pyogenes"],"prefix":"10.1208","volume":"19","author":[{"given":"E.","family":"Burlet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"HogenEsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dunham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Morefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,10]]},"reference":[{"issue":"11","key":"69_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","volume":"5","author":"JR Carapetis","year":"2005","unstructured":"Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal infections. Lancet Infect Dis. 2005;5(11):685\u201394.","journal-title":"Lancet Infect Dis"},{"key":"69_CR2","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.1469-0691.2004.00890.x","volume":"10","author":"RR Reinert","year":"2004","unstructured":"Reinert RR, Lutticken R, Al-Lahham A. High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany. Clin Microbiol Infect. 2004;10:659\u201362.","journal-title":"Clin Microbiol Infect"},{"key":"69_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.ijantimicag.2004.04.010","volume":"24","author":"A Buxbaum","year":"2004","unstructured":"Buxbaum A, Forsthuber S, Sauermann R, Gattringer R, Graninger W, Georgopoulos A. Development of macrolide-resistance and comparative activity of telithromycin in streptococci in Austria, 1996\u20132002. Int J Antimicrob Agents. 2004;24:397\u2013400.","journal-title":"Int J Antimicrob Agents"},{"key":"69_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1146\/annurev.med.51.1.271","volume":"51","author":"DL Stevens","year":"2000","unstructured":"Stevens DL. Streptococcal toxic shock syndrome associated with necrotizing fasciitis. Annu Rev Med. 2000;51:271\u201388.","journal-title":"Annu Rev Med"},{"key":"69_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S1874-5326(07)80030-5","volume-title":"Emerging infections","author":"JM Musser","year":"1998","unstructured":"Musser JM, Krause RM. The revival of group A streptococcal diseases with a commentary on staphylococcal toxic shock syndrome. In: Krause RM, Fauci A, editors. Emerging infections. New York: Academic Press; 1998. p. 185\u2013218."},{"key":"69_CR6","unstructured":"Global Vaccine Action Plan. Secretariat Annual Report 2014. http:\/\/www.who.int\/immunization\/global_vaccine_action_plan\/gvap_secretariat_report_2014.pdf?ua=1"},{"key":"69_CR7","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1001\/jama.1969.03150190037007","volume":"207","author":"BF Massell","year":"1969","unstructured":"Massell BF, Honikman LH, Amezcua J. Rheumatic fever following streptococcal vaccination. Report of three cases. J Am Med Assoc. 1969;207:1115.","journal-title":"J Am Med Assoc"},{"issue":"8","key":"69_CR8","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1128\/JCM.00312-09","volume":"47","author":"AC Steer","year":"2009","unstructured":"Steer AC, Magor G, Jenney AW, Kado J, Good MF, McMillan D, et al. Emm and C-repeat region molecular typing of beta-hemolytic streptococci in a tropical country: implications for vaccine development. J Clin Microbiol. 2009a;47(8):2502\u20139.","journal-title":"J Clin Microbiol"},{"issue":"46","key":"69_CR9","doi-asserted-by":"publisher","first-page":"8175","DOI":"10.1016\/j.vaccine.2011.09.005","volume":"29","author":"JB Dale","year":"2011","unstructured":"Dale JB, Penfound TA, Chiang EY, Walton WJ. New 30-valent M protein-based vaccine evokes crossopsonic antibodies against non-vaccine serotypes of group A streptococci. Vaccine. 2011;29(46):8175\u20138.","journal-title":"Vaccine"},{"key":"69_CR10","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1016\/j.vaccine.2016.03.073","volume":"34","author":"AC Steer","year":"2016","unstructured":"Steer AC, Carapetis JR, Dale JB, Frase JD, Good MF, Guilherme L, et al. Status of research and development of vaccines for Streptococcus pyogenes. Vaccine. 2016;34:2953\u20138.","journal-title":"Vaccine"},{"key":"69_CR11","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/QCO.0b013e328332bbfe","volume":"22","author":"AC Steer","year":"2009","unstructured":"Steer AC, Batzloff MR, Mulholland K, Carapetis JR. Group A streptococcal vaccines: 419 facts versus fantasy. Curr Opin Inf Dis. 2009b;22:544\u201352.","journal-title":"Curr Opin Inf Dis"},{"issue":"4","key":"69_CR12","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1128\/IAI.70.4.2171-2177.2002","volume":"70","author":"MC Hu","year":"2002","unstructured":"Hu MC, Walls MA, Stroop SD, Reddish MA, Beall B, Dale JB. Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immun. 2002;70(4):2171\u20137.","journal-title":"Infect Immun"},{"key":"69_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1476-8518-6-8","volume":"6","author":"R Ulrich","year":"2008","unstructured":"Ulrich R. Vaccine based on a ubiquitous cysteinyl protease and streptococcal pyrogenic exotoxin A protects against Streptococcus pyogenes sepsis and toxic shock. J Immune Based Ther Vaccine. 2008;6:8.","journal-title":"J Immune Based Ther Vaccine"},{"key":"69_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0966-842X(00)89011-3","volume":"3","author":"RG Ulrich","year":"1995","unstructured":"Ulrich RG, Bavari S, Olson M. Bacterial superantigens in human diseases: structure, function and diversity. Trends Microbiol. 1995;3:463\u20138.","journal-title":"Trends Microbiol"},{"key":"69_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3109\/00365549509018991","volume":"27","author":"A Norrby-Teglund","year":"1995","unstructured":"Norrby-Teglund A, Pauksens K, Norgren M, Holm SE. Correlation between serum TNF-alpha and IL-6 levels and severity of group A streptococcal infections. Scand J Infect Dis. 1995;27:125\u201330.","journal-title":"Scand J Infect Dis"},{"key":"69_CR16","doi-asserted-by":"publisher","first-page":"4750","DOI":"10.1128\/IAI.00989-15","volume":"83","author":"RJ Olsen","year":"2015","unstructured":"Olsen RJ, Raghuram A, Cantu C, Hartman MH, Jimenez FE, Lee S, et al. The majority of 9,729 group A streptococcus strains causing disease secrete SpeB cysteine protease: pathogenesis implications. Infect Immun. 2015;83:4750\u20138.","journal-title":"Infect Immun"},{"issue":"9","key":"69_CR17","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S0929-6646(08)60112-6","volume":"107","author":"C Chiang-Ni","year":"2008","unstructured":"Chiang-Ni C, Wu JJ. Effects of streptococcal pyrogenic exotoxin B on pathogenesis of Streptococcus pyogenes. J Formos Med Assoc. 2008;107(9):677\u201385.","journal-title":"J Formos Med Assoc"},{"key":"69_CR18","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1086\/381982","volume":"189","author":"P Akesson","year":"2004","unstructured":"Akesson P, Rasmussen M, Mascini E, von Pawel-Rammingen U, Janulczyk R, Collin M, et al. Low antibody levels against cell wall-attached proteins of Streptococcus pyogenes predispose for severe invasive disease. J Infect Dis. 2004;189:797\u2013804.","journal-title":"J Infect Dis"},{"key":"69_CR19","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1016\/j.vaccine.2014.04.092","volume":"32","author":"G Morefield","year":"2014","unstructured":"Morefield G, Touhey G, Lu F, Dunham A, HogenEsch H. Development of a recombinant fusion protein vaccine formulation to protect against Streptococcus pyogenes. Vaccine. 2014;32:3810\u20135.","journal-title":"Vaccine"},{"issue":"2","key":"69_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1208\/s12248-011-9261-1","volume":"13","author":"GL Morefield","year":"2011","unstructured":"Morefield GL. A rational, systematic approach for the development of vaccine formulations. AAPS J. 2011;13(2):191\u2013200. doi:10.1208\/s12248-011-9261-1.","journal-title":"AAPS J"},{"key":"69_CR21","first-page":"38","volume":"29","author":"A Glenny","year":"1926","unstructured":"Glenny A, Pope C, Waddington H, Wallace U. The antigenic value of toxoid precipitated by potassium alum. J Pathol Bacteriol. 1926;29:38\u201345.","journal-title":"J Pathol Bacteriol"},{"key":"69_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/path.1700340214","volume":"34","author":"A Glenny","year":"1931","unstructured":"Glenny A, Buttle G, Stevens M. Rate of disappearance of diphtheria toxoid injected into rabbits and guinea pigs: toxoid precipitated with alum. J Pathol Bacteriol. 1931;34:267\u201375.","journal-title":"J Pathol Bacteriol"},{"key":"69_CR23","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/jps.22284","volume":"100","author":"T Clapp","year":"2011","unstructured":"Clapp T, Siebert P, Chen D, Jones Braun L. Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stability. J Pharm Sci. 2011;100:388\u2013401.","journal-title":"J Pharm Sci"},{"key":"69_CR24","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3389\/fimmu.2012.00406","volume":"3","author":"H HogenEsch","year":"2013","unstructured":"HogenEsch H. Mechanism of immunopotentiation and safety of aluminum adjuvants. Front Immunol. 2013;3:406.","journal-title":"Front Immunol"},{"issue":"2","key":"69_CR25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/jat.3349","volume":"37","author":"H HogenEsch","year":"2017","unstructured":"HogenEsch H, Dunham A, Burlet E, Lu F, Mosley YC, Morefield G. Preclinical safety study of a recombinant Streptococcus pyogenes vaccine formulated with aluminum adjuvant. J Appl Toxicol. 2017;37(2):222\u201330.","journal-title":"J Appl Toxicol"},{"issue":"9","key":"69_CR26","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1128\/IAI.68.9.5011-5017.2000","volume":"68","author":"M Roggiani","year":"2000","unstructured":"Roggiani M, Stoehr JA, Olmsted SB, Matsuka YV, Pillai S, Ohlendorf DH, et al. Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome. Infect Immun Sep. 2000;68(9):5011\u20137.","journal-title":"Infect Immun Sep"},{"issue":"3","key":"69_CR27","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/INF.0000000000000088","volume":"33","author":"C Silva-Costa","year":"2014","unstructured":"Silva-Costa C, Carri\u00e7o JA, Ramirez M, Melo-Cristino J. Scarlet fever is caused by a limited number of Streptococcus pyogenes lineages and is associated with the exotoxin genes ssa, speA and speC. Pediatr Infect Dis J. 2014;33(3):306\u201310.","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"69_CR28","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/j.1469-0691.2011.03624.x","volume":"18","author":"C Plainvert","year":"2012","unstructured":"Plainvert C, Doloy A, Loubinoux J, Lepoutre A, Collobert G, Touak G, et al. Invasive group A streptococcal infections in adults, France (2006\u20132010). Clin Microbiol Infect. 2012;18(7):702\u201310.","journal-title":"Clin Microbiol Infect"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-017-0069-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-017-0069-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-017-0069-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:57:42Z","timestamp":1744174662000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-017-0069-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,10]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,5]]}},"alternative-id":["69"],"URL":"https:\/\/doi.org\/10.1208\/s12248-017-0069-5","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,10]]},"assertion":[{"value":"4 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In conducting research using animals, the investigator(s) adhered to the Animal Welfare Act Regulations and other Federal Statutes relating to animals and experiments involving animals and the principles set forth in the current version of the Guide for Care and Use of Laboratory Animals, National Research Council.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}}]}}